Atlas Trials

Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension

Clinical trial NCT03293407 · COMPLETED

Trial details

NCT number
NCT03293407
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Hypertension, Pulmonary
Start date
2018-02-01
Primary completion
2019-10-09
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.